Ambroxol Improves Amyloidogenic, NF‐κB, and Nrf2 Pathways in a Scopolamine‐Induced Cognitive Impairment Rat Model of Alzheimer's Disease.

MLA

Faldu, Khushboo Govind, and Jigna Samir Shah. “Ambroxol Improves Amyloidogenic, NF‐κB, and Nrf2 Pathways in a Scopolamine‐Induced Cognitive Impairment Rat Model of Alzheimer’s Disease.” Drug Development Research, vol. 85, no. 7, Nov. 2024, pp. 1–17. EBSCOhost, https://doi.org/10.1002/ddr.70017.

APA

Faldu, K. G., & Shah, J. S. (2024). Ambroxol Improves Amyloidogenic, NF‐κB, and Nrf2 Pathways in a Scopolamine‐Induced Cognitive Impairment Rat Model of Alzheimer’s Disease. Drug Development Research, 85(7), 1–17. https://doi.org/10.1002/ddr.70017

Chicago

Faldu, Khushboo Govind, and Jigna Samir Shah. 2024. “Ambroxol Improves Amyloidogenic, NF‐κB, and Nrf2 Pathways in a Scopolamine‐Induced Cognitive Impairment Rat Model of Alzheimer’s Disease.” Drug Development Research 85 (7): 1–17. doi:10.1002/ddr.70017.